MOREADITH RANDALL (Chief Scientific Officer) sold 13K shares of SERINA THERAPEUTICS, INC. on the open market
Open‑market sale worth $35.0K. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/9/2026ACC: 0001301120-26-000002
Officer· Chief Scientific Officer
Since Feb 2026
-13K
Net shares
Net seller
$35.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
13K acquired · 26K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+13K
Price / share
$0.06
Trade value
$780.00
% of position
New position
1/8/2026
0.00→13K
Common Stock
Direct
Shares
−13K
Price / share
$2.69
Trade value
$34.95K
% of position
New position
1/8/2026
13K→0.00
Total
Net shares
+0.00
Net value
-$34.17K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/8/2026 | M · Option Exercise | +13K | $0.06 | $780.00 | New position | 0.00 | 13K |
| Common Stock Direct | 1/8/2026 | S · Sale | −13K | $2.69 | $34.95K | New position | 13K | 0.00 |
| Total | +0.00 | -$34.17K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
13K shares
Shares
−13K
Strike price
0.06
Held after
339.19K
Exercisable
—
1/8/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock13K shares | 1/8/2026 | M · Option Exercise | −13K | 0.06 | — | 339.19K |